CDSCO Guideline for Action on Spurious &
Amidst the heightened surveillance and enforcement actions initiated by different state licensing authorities (state FDAs)
Warning letters, 483s, Recalls, Import Alerts, Audit observations
Amidst the heightened surveillance and enforcement actions initiated by different state licensing authorities (state FDAs)
The USFDA has released a new draft guidance, Container Closure Systems for Human Drugs and
The USFDA has issued a draft guidance for Establishing Impurity Specifications for Antibiotics in April
The USFDA has released a draft guidance titled “Responding to FDA Form 483 Observations at